title: Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.
authors.forename: M
authors.initials: M
authors.lastname: Benucci
authors.forename: Gobbi F
authors.initials: GF
authors.lastname: Li
authors.forename: A
authors.initials: A
authors.lastname: Del Rosso
authors.forename: M
authors.initials: M
authors.lastname: Manfredi
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab